The possibility that our entire universe merely exists inside a computer simulation is more than an idle science fiction ...

By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

As the Pentagon invests in agentic AI and GPS-free positioning, engineers are fielding systems that can verify identity, ...

Microsoft is launching its own effort toward superintelligence. AI chief Mustafa Suleyman told Axios the company plans to ...

A scene straight out of science fiction just played out in a real lab: a research AI quietly tried to tweak its own code to ...

A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...